structure at the 5-end of the transcribed mRNA, the We performed intrinsic peptide fluorescence ex-TAR (trans-activation responsive element) region, and periments to characterize the interaction between is thus tethered close to the transcription complex (9).
by reversed-phase high-performance liquid chromatography (HPLC) to more than 95% purity based on mass spectroscopic analysis (Shimadzu Compact MALDI). The synthetic peptide was freeze-dried and stored at 020ЊC.
Cloning, expression, and purification of recombinant BP1 SW . BP1 SW was expressed in E. coli. Plasmid pET16b/BP1, which is derived from pTK1 (20) via PCR cloning (Hoffmann et al., unpublished data) and carries the wt BP1 gene, was used as a template for PCR mutagenesis. The PCR reaction was primed by the 3 oligonucleotide 5-TAAGTAACATATGTACCACTCCCAAGTTTGGTTTATCAC-3 replacing cysteine 34 by serine and 37 by tryptophan, and a commercially available T7-terminator primer as the 5 oligonucleotide. The PCR fragment was digested and inserted between NdeI and Bpu1102I sites of pET16b (Novagen, Madison, USA) resulting in plasmid pET16b/BP1Trp. pET16b/BP1Trp was transformed into the E. coli strain DH5a for dideoxy-sequencing (21). Overexpression of BP1 SW was performed in E. coli BL21(DE3). Purification of the BP1 SW peptide was carried out as described for full-length Tat (20). Highly homogeneous preparations of the BP1 SW were used as confirmed by mass spectroscopic analysis (Shimadzu Compact MALDI). For relative maximal quenching of fluorescence induced by binding for urea). The RNA product of correct length was eluted from the gel by the cysteine-modified BP1. using a Schleicher and Schuell electroelution apparatus and subsequent ethanol precipitation. The TAR RNA was dialyzed to remove multivalent ions and other low weight impurities against a high EDTA buffer (10 mM phosphate, 5 mM EDTA, 100mM NaCl, pH a filter with a cutoff at 342 nm. Data were converted using an analog 6.4), a low EDTA buffer (10 mM phosphate, 0.1 mM EDTA, 100mM
to digital converter in an IBM PC-compatible computer and analyzed NaCl, pH 6.4), and finally against water. The pure TAR RNA was off-line using Grafit by fitting of second order reactions. then freeze-dried and stored at 020ЊC.
NMR spectroscopy. All NMR experiments were conducted on a Preparation of the cysteine-modified BP1. Wt BP1 peptide (10 mg/ Bruker AMX 600 spectrometer operating at 600 MHz for 1 H. Phaseml) was incubated for three hours in a reaction buffer containing sensitive detection of the indirectly observed frequencies was 300 mM Tris/HCl, 4 mM EDTA, 50mM DTT, pH 8.5. Addition of 300 achieved by the TPPI method (25 N-labeled peptide the reaction mixture was dialyzed against 10mM phosphate, pH 6.4, at 25 ЊC in 10 mM phosphate buffer, pH 6.4, with 50 mM NaCl. freeze-dried, and stored at 020Њ C. The extent of the cysteine-modifi-Unlabeled HIV-1 TAR, when used, was added in 1.2 fold excess over cation was determined by the method of Ellman (23).
the peptide to ensure that virtually all peptide molecules are bound to TAR. Fluorescence titrations. Fluorescence titrations were performed using a SLM Smart 8000 spectrofluorometer (Colora, Lorch)
RESULTS AND DISCUSSION
equipped with a PH-PC9635 photomultiplier. The buffer contained 10 mM phosphate, 50 mM NaCl, pH 6.4 in a total volume of 1.0 ml. For tyrosine / tryptophan fluorescence the samples were excited at
The wild-type HIV-1 Tat (32-72) peptide BP1 con-272 nm/ 295 nm and the emission intensity was measured at 303 tains no tryptophan residue and is thus not very well nm and 348 nm, respectively (slit width of 1 and 16 nm, respectively). suited for intrinsic fluorescence measurements. HowAll data were corrected for the background intensity of the buffer, ever, it contains two tyrosine residues in the so called for dilution, and for the inner filter effect. Measurements were made in a 0.5 cm pathlength cuvette to minimize the inner filter effect, core domain that is responsible for specific high affinity and the residual effect was estimated from control experiments using binding to TAR. Although the fluorescence quantum free tyrosine and N-acetyltryptophanamide. Data were evaluated yield of tyrosine is much less than that of tryptophan using the program Grafit (Erithacus Software) by fitting a quadratic and also the inner filter effect caused by the TAR RNA is quenched upon addition of TAR RNA (Fig. 1) . The of the BP1 SW peptide with HIV-1 TAR RNA were performed using a change in fluorescence (about 35% quenching) can be in a K d value of approximately 60 nM. The change in amplitude of BP1 SW by addition of TAR is larger than the quenching seen for wt BP1. This is probably due intrinsic fluorescence may also be used to determine the binding stoichiometry and thus the fraction of syn-to the different fluorescence properties of tryptophan compared to tyrosine, but could be also caused by a thesized BP1 active in binding to TAR RNA (active sitetitration). The maximum fluorescence change should stronger interaction of the tryptophan indol group with the TAR RNA in comparison to the phenol groups of be reached when all BP1 molecules are bound to TAR. The fluorescence titration curve decreases linearly to the tyrosines. The changes in tryptophan fluorescence can be used to determine the affinity of BP1 SW to TAR nearly the minimum value, and the breakpoint indicates a stoichiometry of 1:1. This confirmed that all RNA. From these experiments, K d Å 9 nM is obtained for the dissociation constant (Fig. 3 ). This K d is 6 to 7 BP1 molecules were active in binding and interacted equally well with the TAR RNA.
times lower than that determined for wt BP1 and is in the range of the K d determined for the full-length HIVThe titration experiment was performed with a completely reduced BP1 peptide as determined by the 1 Tat (10; 27). This experiment also supports the findmethod of Ellman (23). To investigate whether the ing that the two cysteines within the core domain are two free sulfhydryl groups of the BP1 cysteines are not required for high-affinity binding of BP1 to TAR necessary for the high-affinity binding to TAR, cys-RNA. Thus, the two cysteines within the core sequence teine 34 and cysteine 37 were covalently modified by region may required for a function not related to TAR iodoacetamide and a fluorescence titration experi-binding. Analysis of the binding stoichiometry as dement for this peptide was performed. The titration scribed before resulted in a 1:1 complex. Thus, a recomcurve of modified BP1 with TAR is of nearly identical binant mutant Tat (32-72) peptide was designed that shape compared to the unmodified (Fig. 1) . The data binds to TAR in a wild-type manner, at least with reshowed a quenching of 35% of tyrosine fluorescence spect to its affinity. The presence of the tryptophan and resulted in a dissociation constant (K d ) of approx-within the core region allowed further fluorescence eximately 70 nM. Since the two K d -values of the wild-periments to be used to study the BP1 SW TAR interactype and modified BP1 are nearly identical, we conclude that the sulfhydryl groups of Cys34 and Cys37 within the core domain are not involved in high-affinity binding to HIV-1 TAR RNA.
Because of the low fluorescence quantum yield of tyrosine, the BP1 concentration used here was chosen to be 100 times higher than the determined K d . To gain more insight into the BP1-TAR interaction by fluorescence spectroscopy we accordingly designed the mutant peptide BP1(C37S,C37W) (BP1 SW ; Fig. 2 ) as presence of a tryptophan residue in the peptide offers a potential signal for further fluorescence studies. Thus, BP1 SW can be used in nanomolar concentrations which is in the range of K d , and its tryptophan allows excitation at 295 nm, at which wavelength the inner filter effect of the TAR RNA is minimized. The fluorescence emission spectrum of BP1 SW exhibits a maximum at l max Å 348 nm, which is nearly identical to the emission maximum of N-acetyltryptophanamide, indicating that the tryp- of the intrinsic fluorescence by 80%. The increase in stopped-flow apparatus, whereas an increase of the tryptophan fluorescence was observed in the titration experiment. This could occur if a first rapid binding step occurs, which cannot be observed in the stopped flow machine because of the mixing dead time of ca. 2 ms, and in this step, a relatively large increase in fluorescence occurs which is followed by the decrease observed in the stopped flow experiments. We therefore conclude that the binding reaction is probably a twostep process, as shown in the scheme.
The first step is presumably diffusion controlled, which means we can assume that K /1 is 10 9 M 01 s 01 . Since the  FIG. 4 . Kinetics of binding of HIV-1 BP1 SW , 4 mM, to TAR, 4 mM, stopped flow experiments showed signs of saturation monitored by intrinsic tryptophan fluorescence. The two components at mM concentrations, we conclude the K d value for the were mixed in a stopped-flow apparatus. The data were best fitted first step (i.e. 1/K 1 ) is in the mM range. Assuming a using a second order equation with a rate constant of 3. value of 1 mM (probably an underestimate), k 01 would be 1000 s 01 . In this scheme, the apparent second order rate constant determined at low concentration is given tion in more detail. Moreover, NMR work could be done approximately by K 1 rk /2 (28), and the value obtained to characterize structural properties of the peptide in this work (6.2r10 7 M 01 s 01 ) would lead to a value of RNA complex. The possibility of isotopically labelling 62 s 01 for k /2 . While this is only an indirect estimate, through expression of BP1 SW in E. coli as well as the it is likely that this value lies in the correct range, absence of the cysteines favors BP1 SW , which comprises since fitting the data at 4 mM concentration as a single the whole RNA binding region, for studying the interac-exponential gives a value of 54 s 01 . Not surprisingly, tion with TAR.
one fit in this procedure is not good, and it would only The changes in intrinsic peptide fluorescence de-be expected to find single exponential behavior under scribed here can be used for transient experiments on the conditions used (i.e. equal concentrations of peptide the interaction of BP1 SW with TAR. Quenching of the and RNA) at saturating concentrations of reagents. tryptophan fluorescence occurs in a single phase when However, the condition that this cannot be faster than the two components are mixed at equimolar ratio in a the calculated value of k /2 still holds. It should be stopped-flow apparatus (Fig. 4) . In a control experi-pointed out that a more realistic value for the first step ment performed with BP1 SW alone no fluorescence would be somewhat higher than 1 mM, and this would change was detected, indicating that the peptide's flu-lead to a correspondingly higher value of k /2 . Staying orescence signal was stable during the experiment with the value of 1 mM for 1/K 1 , we can use the affinity (data not shown). The experiment was performed using of the complex (which is given by K 1 r(1 / K 2 ) for the equal concentrations of peptide and RNA at 1 mM, 2 model used) to calculate the value of K 2 (ca. 100), which mM and 4 mM. At all concentrations, good fits to a sec-in turn leads to a value of ca. 0.6 s 01 for k 02 , the rateond order equation were obtained. The rate of the tran-limiting step in dissociation of the complex. Thus, the sient seen was concentration dependent, but fitted sec-stopped-flow experiments lead to first kinetic data of ond order rate constants, which should be independent the Tat-TAR interaction. of concentration for a one step reaction, decreased with
The binding model could be interpreted in the followincreasing concentration. The values obtained were ing manner. The first step represents the formation of 6.2r10 7 01 s 01 at 1, 2 an unspecific peptide RNA complex BP1 SW rTAR* due and 4 mM respectively. This decreasing tendency of the to electrostatic interactions between the positively apparent second order rate constant could be explained charged basic amino acid residues of the peptide and by a two-step mechanism in which the observed fluo-the negatively charged phosphate backbone of the rescence change occurs in the second step. The fact that RNA. The tryptophan residue of the peptide apthe fitted second order rate constant decreases with proaches the RNA, which results in fluorescence enincreasing concentration would be a result of beginning hancement. In the second step, a specific complex saturation of the first step. A further observation BP1 SW rTAR is formed and involves a conformational in this experiment was that the fluorescence was reorganization in both components. Such structural rearrangements of various Tat peptides as well as of the quenched when the two components were mixed in the TAR RNA on complex formation have been reported region with TAR. Similar studies were performed to investigate the HIV-1 Reverse Transcriptase-Primer/ previously (16, 17, 29, 30) . The tryptophan residue within the core sequence region that is responsible for Template interaction (31) .
In order to find evidence which amino acid resithe peptide binding specificity adopts its correct position in the specific BP1 SW -TAR complex. This process dues of BP1 SW interact with TAR, two-dimensional 15 Summarizing, we showed that fluorescence tech-sis of these changes the sequence regions of BP1 SW involved in TAR binding may be identified. Resoniques are well suited to monitor the interaction of Tat derived peptides comprising the whole RNA binding nances of free and TAR bound BP1 SW were assigned
